ROK
27
3
EMC
47
5
ADM
42
5
DTE
38
2
IFF
41
8
HBAN
68
6
AEE
76
3
LB
48
2
DHI
39
7
GRMN
40
3
HCA
53
3
HBI
40
3
LYB
11
3
LH
32
-11
KHC
36
7
CME
48
2
WU
28
-14
CSCO
58
2
EXR
48
6
O
35
5
ROK
27
3
EMC
47
5
ADM
42
5
DTE
38
2
IFF
41
8
HBAN
68
6
AEE
76
3
LB
48
2
DHI
39
7
GRMN
40
3
HCA
53
3
HBI
40
3
LYB
11
3
LH
32
-11
KHC
36
7
CME
48
2
WU
28
-14
CSCO
58
2
EXR
48
6
O
35
5
Financhill
Back

US Physical Therapy Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
46

USPH
US Physical Therapy

Last Price:
$67.28
Seasonality Move:
9.64%
Buy
57

SRPT
Sarepta Therapeutics

Last Price:
$53.80
Seasonality Move:
13.2%
Sell
46
US Physical Therapy (USPH) is a Sell

Is US Physical Therapy a Buy, Sell or Hold?

  • The current US Physical Therapy [USPH] share price is $67.45. The Score for USPH is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • USPH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $53.79. The Score for SRPT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

USPH Stock Price Chart

What is US Physical Therapy's stock price today?

  • The US Physical Therapy share price today is $67.45
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and USPH is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $53.79
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

USPH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.72 Sell
Relative Strength Index (14 RSI): 34.58 Sell
Chaikin Money Flow: -57132 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (68.19 - 74.67) Sell
Bollinger Bands (100): (75.81 - 94.41) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -10.07 Sell
Relative Strength Index (14 RSI): 31.45 Sell
Chaikin Money Flow: -1452145 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.97 - 79.33) Sell
Bollinger Bands (100): (79.54 - 128.22) Sell

USPH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 68.75 Sell
20-day SMA: 70.29 Sell
50-day SMA: 77.89 Sell
200-day SMA: 86.23 Sell
8-day EMA: 68.8 Sell
20-day EMA: 70.82 Sell
50-day EMA: 76.26 Sell
200-day EMA: 85.77 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 52.88 Buy
20-day SMA: 60.79 Sell
50-day SMA: 86.36 Sell
200-day SMA: 118.53 Sell
8-day EMA: 54.47 Sell
20-day EMA: 62.27 Sell
50-day EMA: 80.32 Sell
200-day EMA: 108.23 Sell

US Physical Therapy Earnings Growth & USPH Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.23 per share, an increase this year of $0.01 per share, and an increase next year of $0.28 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.27 per share, a decrease next quarter of $0.11 per share, an increase this year of $3.98 per share, and an increase next year of $6.27 per share.

US Physical Therapy Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):